Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nilsson

Showing results (481-490 of 497) with videos related to

Pageof 50
Sort By:
Blood|June 25, 1998
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patientsE Hellström-Lindberg, T Ahlgren, Y Beguin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 27, 2026
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living QuestionnaireAyesha Fawad, Sophie M van der Landen, Pontus Tideman, et al.
Acta Biomaterialia|July 9, 2019
Effects of gamma radiation sterilization on the structural and biological properties of decellularized corneal xenograftsMohammad Mirazul Islam, Roholah Sharifi, Shamina Mamodaly, et al.
ACS Applied Materials & Interfaces|May 12, 2021
Innate Immune Invisible Ultrasmall Gold Nanoparticles-Framework for Synthesis and EvaluationGeyunjian Harry Zhu, Mohammad Azharuddin, Rakibul Islam, et al.
Elife|February 11, 2021
The allosteric modulation of complement C5 by knob domain peptidesAlex Macpherson, Maisem Laabei, Zainab Ahdash, et al.
Journal of the American Heart Association|January 27, 2025
Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long-Term Cardiovascular MortalityMieke C Louwe, Chrysostomi Gialeli, Annika E Michelsen, et al.
Leukemia|September 13, 2003
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative diseaseR Hast, E Hellström-Lindberg, L Ohm, et al.
Nature Communications|August 14, 2021
RSPO3 is important for trabecular bone and fracture risk in mice and humansKarin H Nilsson, Petra Henning, Maha El Shahawy, et al.
Bone Research|January 10, 2019
NOTUM inhibition increases endocortical bone formation and bone strengthRobert Brommage, Jeff Liu, Peter Vogel, et al.
Nature Communications|March 24, 2025
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trialSonja Loges, Michael Heuser, Jörg Chromik, et al.
Pageof 50

Showing results (481-490 of 497) with videos related to

Sort By:
Pageof 50
Blood|June 25, 1998
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patientsE Hellström-Lindberg, T Ahlgren, Y Beguin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 27, 2026
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living QuestionnaireAyesha Fawad, Sophie M van der Landen, Pontus Tideman, et al.
Acta Biomaterialia|July 9, 2019
Effects of gamma radiation sterilization on the structural and biological properties of decellularized corneal xenograftsMohammad Mirazul Islam, Roholah Sharifi, Shamina Mamodaly, et al.
ACS Applied Materials & Interfaces|May 12, 2021
Innate Immune Invisible Ultrasmall Gold Nanoparticles-Framework for Synthesis and EvaluationGeyunjian Harry Zhu, Mohammad Azharuddin, Rakibul Islam, et al.
Elife|February 11, 2021
The allosteric modulation of complement C5 by knob domain peptidesAlex Macpherson, Maisem Laabei, Zainab Ahdash, et al.
Journal of the American Heart Association|January 27, 2025
Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long-Term Cardiovascular MortalityMieke C Louwe, Chrysostomi Gialeli, Annika E Michelsen, et al.
Leukemia|September 13, 2003
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative diseaseR Hast, E Hellström-Lindberg, L Ohm, et al.
Nature Communications|August 14, 2021
RSPO3 is important for trabecular bone and fracture risk in mice and humansKarin H Nilsson, Petra Henning, Maha El Shahawy, et al.
Bone Research|January 10, 2019
NOTUM inhibition increases endocortical bone formation and bone strengthRobert Brommage, Jeff Liu, Peter Vogel, et al.
Nature Communications|March 24, 2025
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trialSonja Loges, Michael Heuser, Jörg Chromik, et al.
Pageof 50